Its resistance to gastric degradation relative to other peptides of similar length has been studied in rodent models
Research-Use Products Not all products are the same
Specifically: Adults with a BMI of 30 or higher, or 27+ with a weight-related comorbidity (insulin resistance, hypertension, dyslipidemia) People who've plateaued on semaglutide or tirzepatide and are still short of their metabolic goals Those who are committed to a supervised protocol including labs, dosing adjustments, and dietary support Anyone with a longevity focus who understands that reducing visceral adiposity is one of the highest-leverage metabolic interventions available It is not a fit for people looking for a shortcut without lifestyle engagement
For instance, pairing subcutaneous injections with topical products or microneedling can maximize both systemic and localized benefits for skin and hair
The recommended schedule from clinical trials is: Weeks 1-4: 2.5 mg once weekly Weeks 5-8: 5 mg once weekly Weeks 9-12: 7.5 mg once weekly Weeks 13-16: 10 mg once weekly Weeks 17-20: 12.5 mg once weekly Week 21+: 15 mg once weekly (maximum dose) Not everyone follows this exact schedule
Bottom line Menopause is a significant and often challenging, yet entirely natural, phase in a womans life